SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-318183
Filing Date
2020-12-15
Accepted
2020-12-15 17:00:54
Documents
14
Period of Report
2020-12-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d40604d8k.htm   iXBRL 8-K 26165
2 EX-99.1 d40604dex991.htm EX-99.1 7005
6 GRAPHIC g40604g1215213202032.jpg GRAPHIC 3980
  Complete submission text file 0001193125-20-318183.txt   168312

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ziop-20201210.xsd EX-101.SCH 3091
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20201210_lab.xml EX-101.LAB 18908
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20201210_pre.xml EX-101.PRE 11877
7 EXTRACTED XBRL INSTANCE DOCUMENT d40604d8k_htm.xml XML 3539
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 201390217
SIC: 2834 Pharmaceutical Preparations